Scientists at Mount Sinai School of Medicine have discovered the reason behind resilience to stress, vulnerability to depression, also throwing light on the strategy of antidepressants.
The new findings, in the reward circuit of mouse and human brains, have spurred a high tech dragnet for compounds that boost the action of a key gene regulator there, called deltaFosB.
AdvertisementA molecular main power switch - called a transcription factor - inside neurons, deltaFosB turns multiple genes on and off, triggering the production of proteins that perform a cell's activities.
"We found that triggering deltaFosB in the reward circuit's hub is both necessary and sufficient for resilience; it protects mice from developing a depression-like syndrome following chronic social stress," said Eric Nestler, of the Mount Sinai School of Medicine, who led the research team.
"Antidepressants can reverse this social withdrawal syndrome by boosting deltaFosB. Moreover, deltaFosB is conspicuously depleted in brains of people who suffered from depression. Thus, induction of this protein is a positive adaptation that helps us cope with stress, so we're hoping to find ways to tweak it pharmacologically," added Nestler.
The findings have been reported in the journal Nature Neuroscience.
You May Also Like